IVERIC BIO INC's ticker is ISEE and the CUSIP is 46583P102. A total of 171 filers reported holding IVERIC BIO INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $52,151,282 | -32.6% | 2,143,497 | -40.7% | 2.06% | -39.8% |
Q4 2022 | $77,359,768 | +19.3% | 3,613,254 | 0.0% | 3.42% | -14.4% |
Q3 2022 | $64,822,000 | +33.2% | 3,613,254 | -28.6% | 4.00% | +43.8% |
Q2 2022 | $48,664,000 | -42.8% | 5,058,585 | 0.0% | 2.78% | -28.4% |
Q1 2022 | $85,136,000 | +0.7% | 5,058,585 | 0.0% | 3.89% | -9.9% |
Q4 2021 | $84,580,000 | +3.0% | 5,058,585 | 0.0% | 4.32% | +6.7% |
Q3 2021 | $82,151,000 | +157.5% | 5,058,585 | +0.1% | 4.04% | +215.0% |
Q2 2021 | $31,900,000 | +85.4% | 5,055,485 | +81.6% | 1.28% | +64.6% |
Q1 2021 | $17,206,000 | +1478.5% | 2,784,083 | +1665.7% | 0.78% | +1460.0% |
Q4 2020 | $1,090,000 | – | 157,676 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TCG Crossover Management, LLC | 5,141,118 | $110,071,336 | 19.43% |
Deep Track Capital, LP | 7,878,119 | $168,670,528 | 7.08% |
Soleus Capital Management, L.P. | 2,114,728 | $45,276,326 | 6.50% |
MPM BioImpact LLC | 1,059,688 | $22,687,920 | 5.89% |
Finepoint Capital LP | 707,600 | $15,150 | 4.90% |
ACUTA CAPITAL PARTNERS, LLC | 360,500 | $7,718,305 | 4.75% |
Octagon Capital Advisors LP | 1,278,000 | $27,361,980 | 4.26% |
Artia Global Partners LP | 504,615 | $10,803,807 | 4.12% |
Ghost Tree Capital, LLC | 450,000 | $9,635,000 | 4.11% |
Redmile Group, LLC | 4,502,111 | $96,390,197 | 3.94% |